Stay updated on Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial page.

Latest updates to the Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe revision label on the page was updated from Revision: v3.6.6 to Revision: v3.7.0, representing a new version of the page's history component.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision: v3.6.6 replaces v3.6.5 in the page footer, signaling a new build of the site's interface.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page now shows Revision: v3.6.5 instead of v3.6.4, indicating a small site update to the ClinicalTrials.gov interface for the record history page.SummaryDifference0.0%

- Check67 days agoChange DetectedA new revision entry v3.6.4 has been added to the study's revision history and the older v3.6.3 entry has been removed, reflecting an update to the record's version history on the page.SummaryDifference0.0%

- Check81 days agoChange DetectedA new history entry on 2026-07-06 updates the Study Status to Completed and notes that no participants are being recruited; the 2026-02-25 entry was removed from the history.SummaryDifference0.1%

- Check88 days agoChange DetectedThe page's footer revision label was updated to Revision: v3.6.3, replacing the previous v3.6.2.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial page.